Showing results (31-40 of 8,129) with videos related to
Sort By:
Pageof 813
Molecular Pharmaceutics|November 28, 2023
Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor MicroenvironmentShihang Xu, Weicong Luo, Minghui Zhu, et al.Journal of Medicinal Chemistry|September 13, 2023
Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and MetastasisWenjuan Li, Shanhe Li, Gang Xu, et al.Molecular Pharmaceutics|February 26, 2020
Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor MicroenvironmentZhenlei Zhang, Juzheng Zhang, Ming Jiang, et al.Journal of Inorganic Biochemistry|April 11, 2017
Design an anticancer copper(II) pro-drug based on the flexible IIA subdomain of human serum albuminYao Zhang, Zhenlei Zhang, Yi Gou, et al.Oncotarget|August 27, 2016
Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancerYi Gou, Yao Zhang, Jinxu Qi, et al.Journal of Medicinal Chemistry|March 24, 2026
Developing a Multitargeted Anticancer Bi-Copper(II)-Centered Thiocarbohydrazone Agent Based on Lys-199 and His-242 Residues in the IIA Subdomain of Human Serum AlbuminShanhe Li, Xiaojun Wang, Ming Jiang, et al.Journal of Medicinal Chemistry|May 23, 2023
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of CancerXueyu Man, Tongfu Yang, Wenjuan Li, et al.Journal of Medicinal Chemistry|October 5, 2021
Developing a Novel Indium(III) Agent Based on Liposomes to Overcome Cisplatin-Induced Resistance in Breast Cancer by Multitargeting the Tumor Microenvironment ComponentsMing Jiang, Yong Chu, Tongfu Yang, et al.Dalton Transactions (Cambridge, England : 2003)|July 27, 2021
Development of a multi-target anticancer Sn(ii) pyridine-2-carboxaldehyde thiosemicarbazone complexJunmiao Wu, Tongfu Yang, Xiaojun Wang, et al.Chemical Biology & Drug Design|September 17, 2013
X-ray crystallographic and fluorometric analysis of the interactions of rhein to human serum albuminMei Li, Philbert Lee, Yao Zhang, et al.Pageof 813